Concepedia

Giorgio Massimini

GM

Statistics

Publications

25

Citations

5.4K

H-Index

17

Active since

1990

Affiliations

Fondazione IRCCS Istituto Nazionale dei Tumori(Current)

The University of Texas MD Anderson Cancer Center

Merck (Germany)

Hôpital Saint-Louis

Pfizer (United States)

Giorgio Massimini is an author at Fondazione IRCCS Istituto Nazionale dei Tumori specializing in oncology, medicine, and pharmacology.

Top concepts

MedicineOncologyPharmacologyBreast CancerRadiation OncologyPharmacotherapyCancer TherapyCancer ResearchMenopauseGynecology

Publications per year

1990–2021

25

Publications

25

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

R. Charles Coombes, Emma Hall, Lorna J. Gibson et al. · New England Journal of Medicine · 2004 · 1.8K citations · Full text

Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

Sandrine Faivre, Catherine Delbaldo, Karina Vera et al. · Journal of Clinical Oncology · 2005 · 1.1K citations · Full text

Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial

Manfred Kaufmann, Emilio Bajetta, Luc Dirix et al. · Journal of Clinical Oncology · 2000 · 525 citations

A phase 1 study of SU11248 in the treatment of patients with refractory or resistant acute myeloid leukemia (AML) or not amenable to conventional therapy for the disease

Walter Fiedler, Hubert Serve, Hartmut Döhner et al. · Blood · 2005 · 492 citations

Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial

Per Eystein Lønning, Emilio Bajetta, Robin Murray et al. · Journal of Clinical Oncology · 2000 · 318 citations

Rows per page

1–5 of 25